Counterpoints: Should treatment for CML continue indefinitely?

Nicholas J. Short, Elias Jabbour, Gabriel Etienne, François Xavier Mahon

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalClinical Advances in Hematology and Oncology
Volume15
Issue number6
StatePublished - Jun 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this